C
Nutex Health Inc. NUTX
$122.02 -$1.38-1.12% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Revenue 213.98% 269.77% 25.62% 29.12% 19.75%
Total Other Revenue -- -- -- -- --
Total Revenue 213.98% 269.77% 25.62% 29.12% 19.75%
Cost of Revenue 66.37% 113.84% 1.95% 8.60% 11.84%
Gross Profit 760.56% 720.89% 127.64% 96.10% 62.22%
SG&A Expenses 429.79% 200.20% 50.80% 5.81% -4.06%
Depreciation & Amortization 21.64% 12.77% 4.77% 8.72% 4.82%
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 111.48% 118.65% 8.20% 8.14% 8.99%
Operating Income 4,879.93% 2,701.30% 1,396.99% 3,402.10% 134.30%
Income Before Tax 41,392.11% 453.56% 46.97% 176.82% 98.06%
Income Tax Expenses 4,654.10% 387.09% 1,439.32% 209.60% 142.82%
Earnings from Continuing Operations 8,259.23% 460.75% -58.38% 170.56% 92.17%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -16,723.03% -879.74% -59.38% -528.54% -89.97%
Net Income 4,120.33% 295.13% -58.56% 89.54% 92.93%
EBIT 4,879.93% 2,701.30% 1,396.99% 3,402.10% 134.30%
EBITDA 2,070.32% 663.23% 994.45% 1,015.39% 225.45%
EPS Basic 3,631.96% 257.73% -37.84% 90.78% 93.67%
Normalized Basic EPS 10,116.96% 667.71% 35.96% 219.27% 102.49%
EPS Diluted 3,295.38% 248.10% -37.84% 90.78% 93.33%
Normalized Diluted EPS 9,529.82% 633.64% 35.96% 219.27% 102.49%
Average Basic Shares Outstanding 13.77% 23.71% 15.03% 13.54% 11.75%
Average Diluted Shares Outstanding 20.71% 31.61% 15.03% 13.54% 11.75%
Dividend Per Share -- -- -- -- --
Payout Ratio 1.38% -- -- -- -3.43%